| 103678-9 | CTNNB1 gene targeted mutation analysis in Tumor (molecular genetics method) |
| 103955-1 | KRAS Somatic mutation analysis in Tumor (molecular genetics method) |
| 104062-5 | HISGT Histone genes targeted mutation analysis in Tumor (molecular genetics method) |
| 21889-1 | Size Tumor |
| 33728-7 | Size.maximum dimension in Tumor |
| 33729-5 | Size additional dimension in Tumor |
| 42079-4 | Tumor size.collaborative staging |
| 44624-5 | Additional pathological findings in Tumor |
| 81180-2 | Growth pattern in Tumor |
| 81181-0 | Serosal surface involvement in Tumor (qualitative, light microscopy) |
| 81189-3 | Tumor regression in Tumor --post preoperative therapy (qualitative) |
| 84874-7 | Perforation into peritoneal cavity (qualitative) |
| 84875-4 | Tumor perforation |
| 84879-6 | Tumor perforation (qualitative, macroscopy) |
| 84880-4 | Position of rectal tumor in relation to anterior peritoneal reflection in Tumor |
| 84893-7 | Supporting information about local extention AndOr metastasis for staging Tumor Narrative |
| 94076-7 | Mutations/Megabase in Tumor |
| 94077-5 | Tumor mutation burden (qualitative) |
| 95557-5 | Detection basis of Tumor |
| 96449-4 | Cell growth of Tumor culture (Tissue, qualitative) |
| 96893-3 | ERBB2 gene duplication in Tumor (fish) |
| 97761-1 | MLH1 gene methylation analysis in Tumor (molecular genetics method) |
| 98248-8 | Primary or recurrent or distant metastasis in Tumor |
| 98250-4 | Neuroendocrine tumor in Tumor |
| 98390-8 | Percent epithelial component of carcinosarcoma |
| 98391-6 | Percent sarcomatous component of carcinosarcoma |
| 98392-4 | Sarcomatous pattern in carcinosarcoma |